Estrus variation in anxiolytic-like effects of intra-lateral septal infusions of the neuropeptide Y in Wistar rats in two animal models of anxiety-like behavior

Peptides

Volumn 27, Issue 11, 2006, Pages 2722-2730

  Molina Hernández, Miguel ^a   Olivera Lopez, Jorge I ^b   Patricia Tellez Alcantara N ^a   Pérez García, Julían ^a   Teresa Jaramillo, M ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Conflict behavior; Elevated plus maze; Estrus cycle; Lateral septum; Neuropeptide Y

Indexed keywords

NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DIESTRUS; ESTRUS; INSTRUMENTAL CONDITIONING; MAZE TEST; METESTRUS; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; ESTRUS; FEMALE; HUMANS; MAZE LEARNING; NEUROPEPTIDE Y; RATS; RATS, WISTAR; SEPTAL NUCLEI;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33751018268     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.05.017     Document Type: Article

References (83)

1. Baulieu E.E., Schumacher H., Koenig H., Jung-Testas I., and Akwa Y. Progesterone as a neurosteroid: actions within the nervous system. Cell Mol Neurobiol 16 (1996) 143-153
2. Belelli D., Herd M.B., Mitchell E.A., Peden D.R., Vardy A.W., Gentet L., et al. Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 138 (2006) 821-829
3. Bitran D., Hilvers R.J., and Kellog C.K. Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of gamma-aminobutyric acid-benzodiazepine receptor-mediate chloride ion transport. Behav Neurosci 103 (1991) 653-662
4. Bitran D., Shiekh M., and Mcleod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABA-A receptors. J Neuroendocrinol 7 (1995) 171-177
5. Bitran D., and Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology 125 (1996) 65-73
6. Britton K.T., Southerland S., Uden E., Kirby D., Rivier J., and Koob G. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology 132 (1997) 6-13
7. Britton K.T., Akwa Y., Spina M.G., and Koob G. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus-maze. Peptides 21 (2000) 37-44
8. Carette B., and Paulain P. Excitatory effects of dehydroepiandrosterone, its sulfate and pregnenolone-sulfate, applied by iontophoresis and pressure on single neurons in the septo-optic area of guinea pig brain. Neurosci Lett 45 (1984) 205-210
9. Contreras C.M., Molina M., Savedra M., and Martinez L. Lateral septal neuronal firing rate increases during proestrus-estrus in the rat. Physiol Behav 68 (2000) 279-284
10. De María J.E., Livingstone J.D., and Freeman M.E. Ovarian steroids influence the activity of neuroendocrine dopaminergic neurons. Brain Res 879 (2000) 139-147
11. Díaz-Véliz G., Urresta F., Dussaubat N., and Mora S. Progesterone effects on the acquisition of conditioned avoidance responses and other motoric behaviors in intact and ovariectomized rats. Psychoneuroendocrinology 19 (1994) 387-394
12. DonCarlos L.L., Monroy E., and Morrell J.I. Distribution of estrogen receptor immunoreactive cells in the forebrain of the female guinea pig. J Comp Neurol 305 (1991) 591-612
13. Echevarria D.J., Hernandez A., Diogenes A., and Morilak D.A. Administration of the galanin antagonist M40 into lateral septum attenuates shock probe defensive burying behavior in rats. Neuropeptides 39 (2005) 445-451
14. Fernández-Guasti A., and Picazo O. Changes in burying behavior during the estrous cycle: effect of estrogen and progesterone. Psychoneuroendocrinology 17 (1992) 681-689
15. Ferrara G., Serra M., Zammaretti E., Pisu M., Panzica G., Biggio G., et al. Increased expression of the neuropeptide Y receptor Y1 gene in the medial amygdala of transgenic mice induced by long-term treatment with progesterone or allopregnanolone. J Neurochem 79 (2001) 417-425
16. Freeman M.E. The ovarian cycle of the rat. In: Knobil E., and de Neil J. (Eds). The physiology of reproduction (1988), Raven, New York 1893-1928
17. Freund T.F., and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6 (1996) 347-470
18. Gilpin N.W., Stewart R.B., Elder R.L., Kho Y., Murphy J.M., Li T., et al. Sedative and motor-impairing effects of neuropeptide Y and ethanol in selectively bred P and NP rats. Pharmacol Biochem Behav 78 (2004) 65-73
19. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?. Pharmacol Ther 82 (1999) 1-61
20. Handley S.L., and McBlane J.W. An assessment of the elevated X maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Methods 29 (1993) 129-135
21. Hascoët M., Bourin M., Todd K.G., and Couetoux du Tertre A. Anti-conflict effect of 5HT-1A agonists in rats: a new model for evaluating anxiolytic-like activity. J Psychopharmacol 8 (1994) 227-237
22. Hascoët M., and Bourin M. Anticonflict effect of alpidem as compared with the benzodiazepine alprazolam in rats. Pharmacol Biochem Behav 56 (1997) 317-324
23. Heilig M., Söderpalm B., Engel J.A., and Widerlöv E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 98 (1989) 524-529
24. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., et al. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8 (1993) 357-363
25. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004) 213-224
26. Held K., Antonijevic I., Murck H., Kuenzel H., and Steiger A. Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls. Psychoneuroendocrinology 31 (2006) 100-107
27. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54 (1996) 21-30
28. Holmes A., Heilig M., Rupniak N., Steckler T., and Griebel G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24 (2003) 580-588
29. Hurwitz H.M., and Davis H. Depriving rats of food: a reappraisal of two techniques. J Exp Anal Behav 40 (1983) 211-213
30. Jakab R.L., and Leranth C. Septum. In: Paxinos G. (Ed). The rat nervous system (1995), Academic Press, San Diego 405-431
31. Kask A., Rago L., and Harro J. Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam. Eur J Pharmacol 317 (1996) R3-R4
32. Kask A., Rago L., and Harro J. Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res 788 (1998) 345-348
33. Kask A., Lembit R., and Harro J. NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test. NeuroReport 12 (1998) 2713-2717
34. Kask A., Nguyen H.P., Pabst R., and Hörsten S. Neuropeptide Y Y1 receptor-mediated anxioysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety. Neuroscience 104 (2001) 799-806
35. Kask A., Harro J., Von Hörsten S., Redrobe J.P., Dumont Y., and Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26 (2002) 259-283
36. Kokare D., Dandekar M., Chopde C., and Subhedar N. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Res 1043 (2005) 107-114
37. Krysiak R., Obuchowicz E., and Herman Z.S. Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone. Neuropeptides 34 (2000) 148-157
38. Leer M.N., Bradbury A., Maloney J.C., and Stewart C.N. Elevated shock threshold in sexually receptive female rats. Physiol Behav 42 (1988) 617-620
39. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1006
40. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABA-A receptor: mechanism of action and physiological significance. Prog Neurobiol 38 (1992) 379-395
41. Martel J.C., St-Pierre S., and Quirion R. Neuropeptide Y receptors in rat brain: autoradiographic localization. Peptides 7 (1986) 55-60
42. Martínez-Mota L., Estrada-Camarena E., López-Rubalcava C., Contreras C.M., and Fernández-Guasti A. Interaction of desipramine with steroid hormones on experimental anxiety. Psychoneuroendocrinology 25 (2000) 109-120
43. Melia K.R., and Davis M. Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam. Physiol Behav 49 (1991) 603-611
44. Menard J., and Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci Biobehav Rev 23 (1999) 591-613
45. Migita K., Loewy A.D., Ramabhadran T., Krause J.E., and Waters S.M. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Res 889 (2001) 23-37
46. Millan M. The neurobiology and control of anxious states. Prog Neurobiol 70 (2003) 83-244
47. Molina-Hernández M., and Téllez-Alcántara P. Estrus variation in anticonflict effects of midazolam microinjected into septal nuclei in female Wistar rats. Pharmacol Biochem Behav 68 (2001) 531-537
48. Molina-Hernández M., Contreras C.M., and Téllez-Alcántara P. Diazepam increases the number of punished responses in a conflict-operant paradigm during late proestrus and estrus in the Wistar rat. Neuropsychobiology 43 (2001) 29-33
49. Molina-Hernández M., Perez J., and Olivera J. Female Wistar rats tested during late proestrus or during pregnancy and ovariectomized rats tested alter receiving progesterone or allopregnanolone displayed reduced conflict behavior. Prog Neuro-Psychopharmacol Biol Psychiatr 26 (2002) 839-844
50. Molina-Hernández M., Téllez-Alcántara P., Perez J., Olivera J., and Jaramillo T. Anti-conflict-like actions of intralateral septal infusions of allopregnanolone in Wistar rats. Pharmacol Biochem Behav 75 (2003) 397-404
51. Munglani R., Hudspith M.J., and Hunt S.P. The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive. Drugs 52 (1996) 371-389
52. Nakamura N.H., and McEwen B.S. Changes in interneuronal phenotypes regulated by estradiol in the adult rat hippocampus: a potential role for neuropeptide Y. Neuroscience 136 (2005) 357-369
53. National Institutes of Health. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
54. Obuchowicz E., Krysiak R., and Herman Z. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?. Neurosci Biobehav Rev 28 (2004) 595-610
55. Onteniente B., Tago H., Kimura H., and Maeda T. Distribution of g-aminobutiric acid-immunoreactive neurons in the septal region of the rat brain. J Comp Neurol 218 (1986) 422-430
56. Owens M.J., Bissette G., and Nemeroff C.B. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 4 (1989) 196-202
57. Pandaranandaka J., Poonyachoti S., and Kalandakanond S. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats. Physiol Behav 87 (2006) 828-835
58. Panula P., Revuelta A.V., Cheney D.L., Wu J.-Y., and Costa E. An immunohistochemical study on the location of GABAergic neurons in the rat septum. J Comp Neurol 222 (1984) 69-80
59. Panzica G.C., Aste N., Viglietti-Panzica C., and Ottinger M.A. Structural sex differences in the brain: influence of gonadal steroids and behavioral correlates. J Endocrinol Invest 18 (1995) 232-252
60. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J 6 (1992) 2311-2322
61. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1982), Academic Press, New York
62. Pearlstein T.B. Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy?. Am J Obstet Gynecol 173 (1995) 646-653
63. Pesold C., and Treit D. The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 638 (1994) 295-301
64. Pesold C., and Treit D. The neuroanatomical specificity of the anxiolytic effects of intraseptal infusions of midazolam. Brain Res 710 (1996) 161-168
65. Picazo O., and Fernández-Guasti A. Changes in experimental anxiety during pregnancy and lactation. Physiol Behav 54 (1993) 295-299
66. Picazo O., and Fernández-Guasti A. Antianxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test. Brain Res 680 (1995) 135-141
67. Rainbow T.C., Parsons B., and McEwen B.S. Sex differences in rat brain oestrogen and progestin receptors. Nature 300 (1982) 648-649
68. Robel P., and Baulieu E.E. Neurosteroids: biosynthesis and function. Trends Endocrinol Met 5 (1994) 1-8
69. Rodgers R.L., and Dalvi A. Anxiety, defense and the elevated plus-maze. Neurosci Biobehav Rev 21 (1997) 801-810
70. Rodriguez J.F., Howard J.L., Pollard G.T., and Hendricks S.E. Effect of ovarian hormones on conflict behaviour. Psychoneuroendocrinology 9 (1984) 293-300
71. Rugarn O., Hammar M., and Theodorsson E. Progesterone and norethisterone have different effects on tachykinin-like immunoreactivity in rat cortex and striatum. Regul. Peptides 101 (2001) 87-91
72. Rose J.D. Changes in limbic neuronal function during hormonal induction of lordosis in behaving hamsters. Physiol Behav 51 (1992) 1135-1145
73. Sajdyk T.J., Shekhar A., and Gehlert D.R. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 38 (2004) 225-234
74. Sheehan T.P., Chambers R.A., and Russel D.S. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Rev 46 (2004) 71-117
75. Simerly R.B., Chang C., Muramatsu M., and Swanson L.W. Distribution of androgen and estrogen receptor MRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 294 (1990) 76-95
76. Smith S.S., Waterhouse B.D., Chapin J.K., and Woodward D.J. Progesterone alters GABA and glutamate responsiveness: a possible mechanism for its anxiolytic action. Brain Res 400 (1987) 353-359
77. Thomas E., Yadin E., and Strickland C.E. Septal activity during classical conditioning: a regional comparison. Brain Res 547 (1991) 303-308
78. Toney T.W., Pawsat D.E., Fleckenstein A.E., Lookingland K., and Moore K.E. Evidence that prolactin mediates the stimulatory effects of estrogen on tuberoinfundibular dopamine neurons in female rats. Neuroendocrinology 55 (1992) 282-289
79. Treit D., Pesold C., and Rotzinger S. Dissociating the antifear effects of septal and amygdala lesions using two pharmacologically validated models of rat anxiety. Behav Neurosci 107 (1993) 770-785
80. Van Goozen S.H.M., Frijda N.H., Wiegant V.M., Endert E., and Van de Poll N.E. The premenstrual phase and reactions to aversive events: a study of hormonal influences on emotionality. Psychoneuroendocrinology 21 (1996) 479-497
81. Wieck A. Affective disorders in the postnatal period and the premenstruum: biological mechanisms. Eur Psychiatr 13 (1998) 178
82. Yadin E., and Thomas E. Septal correlates of conditioned inhibition and excitation in rats. J Comp Physiol Psychol 95 (1981) 331-340
83. Yadin E., Thomas E., Grishka H.L., and Strickland C.E. The role of the lateral septum in anxiolysis. Physiol Behav 53 (1993) 1077-1083